Clinical Trial End Points in Severe COVID-19

Mayo Clin Proc. 2020 Aug;95(8):1578-1580. doi: 10.1016/j.mayocp.2020.05.025. Epub 2020 Jun 6.

¹ Department of Medicine, University of Connecticut, Farmington. Electronic address: dr.aakashdesai@gmail.com.
² Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis.
³ Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.
⁴ Department of Oncology, Queen's University, Kingston, Ontario, Canada; Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada; Division of Cancer Care and Epidemiology, Queen's University, Kingston, Ontario, Canada.

No abstract available

Publication types